Abstract

FREP1 in mosquito midguts facilitates Plasmodium falciparum parasite transmission. The fibrinogen-like (FBG) domain of FREP1 is highly conserved (>90% identical) among Anopheles species from different continents, suggesting that anti-FBG antibodies may block malaria transmission to all anopheline mosquitoes. Using standard membrane-feeding assays, anti-FREP1 polyclonal antibodies significantly blocked transmission of Plasmodium berghei and Plasmodium vivax to Anopheles gambiae and Anopheles dirus, respectively. Furthermore, in vivo studies of mice immunized with FBG achieved >75% blocking efficacy of P. berghei to A. gambiae without triggering immunopathology. Anti-FBG serum also reduced >81% of P. falciparum infection to A. gambiae Finally, we showed that FBG interacts with Plasmodium gametocytes and ookinetes, revealing the molecular mechanism of its antibody transmission-blocking activity. Collectively, our data support that FREP1-mediated Plasmodium transmission to mosquitoes is a conserved pathway and that targeting the FBG domain of FREP1 will limit the transmission of multiple Plasmodium species to multiple Anopheles species.

Highlights

  • FREP1 in mosquito midguts facilitates Plasmodium falciparum parasite transmission

  • A. gambiae mosquitoes were fed with P. berghei–infected blood mixed with rabbit anti-FREP1 serum (1:1 dilution, final titer units, 5 ϫ 104), and we subsequently examined the number of developing oocysts in mosquito midg

  • Because FREP1 localizes in the mosquito midgut peritrophic matrix, it is readily accessible to antibodies in co-ingested blood

Read more

Summary

Results

We examined the FREP1 orthologs among anopheline mosquitoes to find conserved regions. Because there is a highly conserved FBG domain among anopheline orthologs, we determined whether anti-FREP1 antibody would inhibit transmission of other Plasmodium species to additional Anopheles species To address this question, A. gambiae mosquitoes were fed with P. berghei–infected blood mixed with rabbit anti-FREP1 serum (1:1 dilution, final titer units, 5 ϫ 104), and we subsequently examined the number of developing oocysts in mosquito midg-. The results showed that the anti-FREP1 antibody significantly reduced the number of oocysts per midgut, more than 2-fold, compared with the control serum (Fig. 2b). The results were consistent in two biological replicates that were conducted with different P. vivax–infected human blood Together, these data support that anti-FREP1 antibodies can block the transmission of multiple species of malaria parasites to multiple mosquito species. Sexual-stage parasites and gametocytes are within red blood cells; the DAPI

F: Negative control
Discussion
Ethics statement
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call